Main Menu

FDA Head Reveals New Details About Agency’s CBD Regulation Plans

FDA Head Reveals New Details About Agency’s CBD Regulation Plans

Food and Drug Administration (FDA) Commissioner Scott Gottlieb revealed new details about plans to pursue alternative pathways for CBD regulation and also acknowledged that federal prohibition drives research into medical marijuana overseas on Wednesday.

Gottlieb’s latest comments were in response to questions from Reps. Barbara Lee (D-CA), Chellie Pingree (D-ME) and Mark Pocan (D-WI) during a hearing before a House Appropriations subcommittee.

FDA Head Reveals New Details About Agency’s CBD Regulation Plans






Comments are Closed